Journal of Clinical Oncology

Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in the TRIPLETE Study

A Antonio Avallone (Antonio Avallone, MD, and Alfonso De Stefano, MD, PhD, Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori—IRCCS—Fondazione G. Pascale, Napoli, Italy; and Davide Ciardiello, MD, PhD, Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy) A Alfonso De Stefano (Antonio Avallone, MD, and Alfonso De Stefano, MD, PhD, Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori—IRCCS—Fondazione G. Pascale, Napoli, Italy; and Davide Ciardiello, MD, PhD, Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy) D Davide Ciardiello
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 44, Issue 23
Published August 10, 2026
Pages 2253-2254
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

A

Antonio Avallone

Antonio Avallone, MD, and Alfonso De Stefano, MD, PhD, Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori—IRCCS—Fondazione G. Pascale, Napoli, Italy; and Davide Ciardiello, MD, PhD, Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy

A

Alfonso De Stefano

Antonio Avallone, MD, and Alfonso De Stefano, MD, PhD, Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori—IRCCS—Fondazione G. Pascale, Napoli, Italy; and Davide Ciardiello, MD, PhD, Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy

D

Davide Ciardiello

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001